Example: Heart Attack
Clinical Trials Sponsored by Aditya S. Pandey, MD
Total 1 results
-
NCT04566991RecruitingAneurysmal Subarachnoid Hemorrhage
We use cookies to ensure that we give you the best experience on our website. For more details carefully read our Privacy and Cookies Policy. ...>>>You can change your preferences or withdraw your consent at any time by deleting the cookies from your website or computer as described in the policy. Please accept it and choose your preferences by ticking the corresponding boxes in the "Manage Settings" section below. Please carefully read our Terms of Service before you proceed with using any part of this website.
Show vendors
Sponsors and Collaborators
- Cairo University
- Charlotte Gastroenterology and Hepatology
- Groupe Pasteur Mutualité
- Universitätsklinikum Tulln
- Novartis Pharmaceuticals
- Mid-Atlantic Nutrition Obesity Research Center
- Mayo Clinic
- National Cancer Institute (NCI)
- GlaxoSmithKline
- Amphia Hospital
- Beijing DMS Pharma Ltd.
- Pfizer
- First Hospital of Shijiazhuang City
- Assistance Publique - Hôpitaux de Paris
- Assiut University
- M.D. Anderson Cancer Center
- AstraZeneca
- John Kempen
- BKK Mobil Oil
- Hospital, Vannes
- View Full List
Medical Conditions
- Gastroesophageal Reflux Disease With Dyspepsia Symptoms
- Stroke
- Coronary Artery Disease
- Blood Coagulation Disorder Due to Liver Disease
- Breast Cancer
- Blood Flow Indexes
- Pain
- Prostate Cancer
- Infection Gastrointestinal
- Obesity
- Leucocytosis
- HIV Infections
- Asthma
- Corpus Callosum Malformation
- Nutritional Status in Hospitalised Geriatric Patients
- Depression
- Pre-terminal Cancer
- ASA 1-2 Requiring Intravenous Cannulation for General Anaesthesia
- Hematopoietic and Lymphoid Cell Neoplasm
- Hypertension
- View Full List
Drug Interventions
- Cisplatin
- docetaxel
- M4344 10 mg BIW
- Prednisone
- Iodixanol, Ioversol, Iopromide
- enalapril and other angiotensin converting enzyme inhibitors; losartan and other angiotensin receptor blockers
- Carboplatin
- CA-008
- Dexamethasone
- Bevacizumab
- Efficacy of Enbrel subcutaneously at Week 36
- Dicofenac
- Cyclophosphamide
- AC-150A 0.1%
- Capecitabine
- Gemcitabine
- Paclitaxel
- Esketamine Hydrochloride 28 Mg in 0.2 mL NASAL SOLUTION [Spravato]
- 100 mg INX-08189 QD
- Triamcinolone Acetonide 4 mg intravitreal injection
- View Full List
CROs by country
- Contract Research Organizations in Cote d'Ivoire
- Contract Research Organizations in Czech Republic
- Contract Research Organizations in Denmark
- Contract Research Organizations in Ghana
- Contract Research Organizations in Hong Kong
- Contract Research Organizations in Ireland
- Contract Research Organizations in Jamaica
- Contract Research Organizations in Luxembourg
- Contract Research Organizations in Panama
- Contract Research Organizations in Poland
- Contract Research Organizations in Sri Lanka
- Contract Research Organizations in Uruguay
- Contract Research Organizations in Uzbekistan
- CRO list by country